Malaria vaccines

Parasitology Today

Volumn 16, Issue 10, 2000, Pages 444-447

  Anders, R F ^a   Saul, A ^b  

^a LA TROBE UNIVERSITY   (Australia)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MALARIA VACCINE;

ANTIBODY RESPONSE; IMMUNIZATION; MALARIA; MEDICAL RESEARCH; NONHUMAN; PARASITEMIA; PLASMODIUM; REVIEW; SPOROZOITE;

ANIMALS; ANTIGENS, PROTOZOAN; HUMANS; MALARIA VACCINES; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS;

EID: 0034307621     PISSN: 01694758     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-4758(00)01784-1     Document Type: Review

References (23)

1. Clyde D.F.et al. Immunization of man against sporozoite-induced falciparum malaria. Am. J. Med. Sci. 266:1973;169-177.
2. Herrington D.et al. Successful immunization of humans with irradiated malaria sporozoites. humoral and cellular responses of the protected individuals Am. J. Trop. Med. Hyg. 45:1991;539-547.
3. Egan J.E.et al. Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites. Am. J. Trop. Med. Hyg. 49:1993;166-173.
4. Potocnjak P.et al. Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection. J. Exp. Med. 151:1980;1504-1513.
5. Herrington D.et al. Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites. Nature. 328:1987;257-259.
6. Ballou W.R.et al. Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine. Lancet. i:1987;1277-1281.
7. Rogers W.O., Hoffman S.L. Malaria vaccines. Wahlgren M., Perlmann P. Malaria. 1999;439-493 Harwood Academic Publishers.
8. Stoute J.A.et al. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. New Engl. J. Med. 336:1997;86-91.
9. Chappel J.A., Holder A.A. Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognise the first growth factor-like domain of merozoite surface protein-1. Mol. Biochem. Parasitol. 60:1993;303-311.
10. Blackman M.J.et al. Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein. J. Exp. Med. 180:1994;389-393.
11. Saul A.et al. Human phase I vaccine trials of 3 recombinant asexual stage malaria antigens with Montanide ISA720 adjuvant. Vaccine. 17:1999;3145-3159.
12. Genton B.et al. Safety and immunogenicity of a three-component blood-stage malaria vaccine in adults living in an endemic area of Papua New Guinea. Vaccine. 18:2000;2504-2511.
13. Collins W.E.et al. Protective immunity induced in squirrel monkeys with recombinant apical membrane antigen-1 of Plasmodium fragile. Am. J. Trop. Med. Hyg. 51:1994;711-719.
14. Crewther P.E.et al. Protective immune responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of strain-specific epitopes. Infect. Immun. 64:1996;3310-3317.
15. Biggs B.A.et al. Adherence of infected erythrocytes to venular endothelium selects for antigenic variants of Plasmodium falciparum. J. Immunol. 149:1992;2047-2054.
16. Roberts D.J. Rapid switching to multiple antigenic and adhesive phenotypes in malaria. Nature. 357:1992;689-692.
17. Marsh K., Howard R.J. Antigens induced on erythrocytes by P. falciparum: expression of diverse and conserved determinants. Science. 231:1986;150-153.
18. Taylor H.M.et al. A study of var gene transcription in vitro using universal var gene primers. Mol. Biochem. Parasitol. 105:2000;13-23.
19. Tachado S.D.et al. Signal transduction in macrophages by glycosylphosphatidylinositols of Plasmodium, Trypanosoma, and Leishmania: activation of protein tyrosine kinases and protein kinase C by inositolglycan and diacylglycerol moieties. Proc. Natl. Acad. Sci. U. S. A. 94:1997;4022-4027.
20. Hedstrom R.C.et al. In vitro expression and in vivo immunogenicity of Plasmodium falciparum pre-erythrocytic stage DNA vaccines. Int. J. Mol. Med. 2:1998;29-38.
21. Moreno C.A.et al. Preclinical evaluation of a synthetic Plasmodium falciparum MAP malaria vaccine in Aotus monkeys and mice. Vaccine. 18:1999;89-99.
22. Shi Y.P.et al. Immunogenicity and in vitro protective efficacy of a recombinant multistage Plasmodium falciparum candidate vaccine. Proc. Natl. Acad. Sci. U. S. A. 96:1999;1615-1620.
23. Degano P.et al. Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara. enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models Vaccine. 18:1999;623-632.